Proteomic profiling identifies novel circulating markers associated with bronchiectasis in cystic fibrosis.
Emily M DeBoerMiranda E KroehlBrandie D WagnerFrank J AccursoJ Kirk HarrisDavid A LynchScott D SagelRobin R DeterdingPublished in: Proteomics. Clinical applications (2017)
Imaging outcomes were more strongly correlated with circulating proteins than age or spirometry values. The unique SOMAscan proteomic platform identifies several novel proteins in blood that are associated with bronchiectasis and that may serve as clinically useful biomarkers in children with CF.